Shire confirme ses objectifs, malgré une chute de 22% de ses profits au 1T L'Agefi (Abonnement) Le Vyvanse, que le groupe veut imposer comme le successeur de l'Adderall, a ainsi vu les siennes bondir de 32%. Conforté par cette forte progression de ses ... |
 Telegraph.co.uk | Strong Sales of Vyvanse Leads to Higher Shire Profits TopNews New Zealand The company has attributed that growth mainly to higher sales of Vyvanse, Shire's popular drug used for the treatment of attention deficit and hyperactivity ... Pharmaceutical company Shire uses strategy of harvesting drugs from rivals Telegraph.co.uk Shire results impress, hopeful about Gaucher drug Vpriv Pharma Times all 3 news articles » |
 TopNews United Kingdom (blog) | Shire profits higher on sales of Vyvanse BBC News The growth was mainly due to higher sales of Vyvanse, its drug treating attention deficit and hyperactivity disorder (ADHD). Another contributor was its ... Shire Rises as Unexpected Adderall Gains Lift Profit BusinessWeek Shire plc Q4 2009 Earnings Call Transcript Seeking Alpha (blog) Shire Prepares for Rare Disease Launches in 2010 Morningstar.com TopNews United Kingdom (blog) - Barron's (blog) - Daily Mail all 44 news articles » |